AbbVie
PublicTrace currently links 3125 federal records across 10 source groups to this company, spanning 2016-01-02 through 2026-10-11. The largest record category is federal civil litigation. Inspect sample evidence and follow the original agency links before using a record in a consequential decision.
Selected public evidence
actions · 2016-04-27 to 2024-10-02
OSHA · DOLWorkplace safety & labor11records · 2020-01-01 to 2024-01-01
EPAEnvironmental record2records · 2024-01-01 to 2024-01-01
LDAFederal lobbying45filings · 2016-01-20 to 2026-01-20
SECSecurities disclosures210filings · 2017-02-17 to 2026-10-11
4 additional source groups are available in the complete history.
Sample federal records
Showing up to five records from selected enforcement, operating-history, lobbying, disclosure, and restricted-party categories. This is not an exhaustive search.
Federal enforcement actions
Showing 5 of 10
-
Lack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal. FDA · Enforcement Why linked: Attributed by a source-name match; verify the named party.View on openFDA ↗
-
Lack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal. FDA · Enforcement Why linked: Attributed by a source-name match; verify the named party.View on openFDA ↗
-
Labeling: Wrong Barcode- One (1) of every forty (40) unit dose blister will contain incorrect barcode information that causes a 125mcg unit dose is scanned as 200mcg unit dose. FDA · Enforcement Why linked: Attributed by a source-name match; verify the named party.View on openFDA ↗
-
The FTC filed a complaint in federal district court in September 2014 charging that AbbVie Inc. and its partner Besins Healthcare Inc. illegally blocking American consumers’ access to lower-cost alternatives to Androgel… FTC · Enforcement Why linked: Attributed by a source-name match; verify the named party.FTC case page ↗
-
Pharmaceutical companies AbbVie Inc. and Allergan plc have agreed to divest assests to settle Federal Trade Commission charges that AbbVie's proposed $63 billion acquisition of Allergan would violate federal antitrust… FTC · Enforcement Why linked: Attributed by a source-name match; verify the named party.FTC case page ↗
Workplace safety & labor
Showing 5 of 11
-
OSHA 300A summary — AbbVie Cambridge Research Center (2024)OSHA ITA establishment-level data archive ↗
OSHA 300A 2024 — no recordable injuries
OSHA · Registration Why linked: Attributed through the establishment record; verify the named party. -
OSHA 300A summary — AbbVie (Abbott Park ) (2024)OSHA ITA establishment-level data archive ↗
OSHA 300A 2024 — no recordable injuries
OSHA · Registration Why linked: Attributed through the establishment record; verify the named party. -
OSHA 300A summary — AbbVie Cambridge Research Center (2023)OSHA ITA establishment-level data archive ↗
OSHA 300A 2023 — 0 injuries, 0 days-away cases, 0 deaths
OSHA · Registration Why linked: Attributed through the establishment record; verify the named party. -
OSHA 300A summary — AbbVie, Inc (2023)OSHA ITA establishment-level data archive ↗
OSHA 300A 2023 — no recordable injuries
OSHA · Registration Why linked: Attributed through the establishment record; verify the named party. -
OSHA 300A summary — AbbVie, Inc (2022)OSHA ITA establishment-level data archive ↗
OSHA 300A 2022 — no recordable injuries
OSHA · Registration Why linked: Attributed through the establishment record; verify the named party.
Environmental record
Showing 2 of 2
-
TRI report for ABBVIE LTD (2024)View original source ↗
Toxics release filing — facility ABBVIE LTD
EPA · Release Report Why linked: Attributed through PublicTrace entity resolution; verify the named party. -
TRI report for ABBVIE-NORTH CHICAGO FACILITY (2024)View original source ↗
Toxics release filing — facility ABBVIE-NORTH CHICAGO FACILITY
EPA · Release Report Why linked: Attributed through PublicTrace entity resolution; verify the named party.
Federal lobbying
Showing 5 of 45
-
Lobbying — 4th Quarter - Report (CPT; HCR; LBR; MMM; TAX; TRD) via ABBVIE, INC. — $1,330,000 LDA · Lobbying Filing Why linked: Attributed by a source-name match; verify the named party.Senate LDA filing ↗
-
Lobbying — 3rd Quarter - Report (CPT; HCR; LBR; MMM; TAX; TRD) via ABBVIE, INC. — $980,000 LDA · Lobbying Filing Why linked: Attributed by a source-name match; verify the named party.Senate LDA filing ↗
-
Lobbying — 2nd Quarter - Report (CPT; HCR; LBR; MMM; TAX; TRD) via ABBVIE, INC. — $1,160,000 LDA · Lobbying Filing Why linked: Attributed by a source-name match; verify the named party.Senate LDA filing ↗
-
Lobbying — 1st Quarter - Report (CPT; HCR; LBR; MMM; TAX) via ABBVIE, INC. — $2,110,000 LDA · Lobbying Filing Why linked: Attributed by a source-name match; verify the named party.Senate LDA filing ↗
-
Lobbying — 4th Quarter - Report (CPT; HCR; LBR; MMM; TAX) via ABBVIE, INC. — $1,080,000 LDA · Lobbying Filing Why linked: Attributed by a source-name match; verify the named party.Senate LDA filing ↗
Securities disclosures
Showing 5 of 210
-
Registration SEC · Registration Why linked: Linked by SEC CIK 0001551152.Source link unavailable
-
8-K filingView original source ↗
Form 8-K - Current report - Item 2.02 Item 9.01
SEC · Filing Why linked: Linked by SEC CIK 0001551152. -
4 filingView original source ↗
Form 4 - Statement of changes in beneficial ownership of securities
SEC · Filing Why linked: Linked by SEC CIK 0001551152. -
8-K filingView original source ↗
Form 8-K - Current report - Item 7.01 Item 9.01
SEC · Filing Why linked: Linked by SEC CIK 0001551152. -
8-K filingView original source ↗
Form 8-K - Current report - Item 8.01 Item 9.01
SEC · Filing Why linked: Linked by SEC CIK 0001551152.
These records are currently attributed to AbbVie through PublicTrace’s entity-resolution process. Verify the named party and original source before relying on a match. An absent category is not proof that no relevant record exists.
3103 additional records · Complete history adds every source group, date/source filters, exports, saved monitoring, and API access.